1146MO Interim Analysis of CABONEN: A Multicenter Phase II Trial Investigating Cabozantinib in Patients with Advanced, Low Proliferative NEN G3

A.O. Koenig,J. Reinecke, J. Halfen, K. Lang, U. König, R. Tostmann, N. Kirchhof,T. Asendorf,D. Hörsch, A. Kröcher, M. Quante, V. Ellenrieder, N. Schulte, T. Wirth,A. Weich,L. Apostolidis,S. Krug,A. Rinke,M.E. Pavel

Annals of Oncology（2024）

Cited 0|Views5

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined